About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
NeuroMolecular Medicine
›
top-articles
NeuroMolecular Medicine
3.4
(top 10%)
impact factor
895
(top 20%)
papers
32.4K
(top 10%)
citations
83
(top 10%)
h
-index
3.5
(top 10%)
impact factor
961
all documents
34.5K
doc citations
130
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Neurogenesis and Exercise: Past and Future Directions
NeuroMolecular Medicine
2008
521
2
An Overview of APP Processing Enzymes and Products
NeuroMolecular Medicine
2010
515
3
Functional Alterations in Memory Networks in Early Alzheimer’s Disease
NeuroMolecular Medicine
2010
497
4
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
NeuroMolecular Medicine
2004
463
5
Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders
NeuroMolecular Medicine
2003
415
6
Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases
NeuroMolecular Medicine
2003
410
7
Differential Expression of Oxidative Phosphorylation Genes in Patients With Alzheimer's Disease: Implications for Early Mitochondrial Dysfunction and Oxidative Damage
NeuroMolecular Medicine
2004
361
8
Hormetic Dietary Phytochemicals
NeuroMolecular Medicine
2008
285
9
Manganese and its Role in Parkinson’s Disease: From Transport to Neuropathology
NeuroMolecular Medicine
2009
258
10
Neurological Benefits of Omega-3 Fatty Acids
NeuroMolecular Medicine
2008
248
11
Leukocyte Recruitment and Ischemic Brain Injury
NeuroMolecular Medicine
2010
239
12
Physical Activity and the Regulation of Neurogenesis in the Adult and Aging Brain
NeuroMolecular Medicine
2008
224
13
Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
NeuroMolecular Medicine
2009
222
14
Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease
NeuroMolecular Medicine
2011
222
15
Disruption of Neurogenesis in the Subventricular Zone of Adult Mice,and in Human Cortical Neuronal Precursor Cells in Culture, by Amyloid β-Peptideby Amyloid β-Peptide
NeuroMolecular Medicine
2002
218
16
Energetics and Oxidative Stress in Synaptic Plasticity and Neurodegenerative Disorders
NeuroMolecular Medicine
2002
209
17
Neuroplasticity of Dopamine Circuits After Exercise: Implications for Central Fatigue
NeuroMolecular Medicine
2008
198
18
Mitochondrial Medicine for Aging and Neurodegenerative Diseases
NeuroMolecular Medicine
2008
197
19
Botanical Phenolics and Brain Health
NeuroMolecular Medicine
2008
189
20
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
NeuroMolecular Medicine
2002
181
21
Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
NeuroMolecular Medicine
2014
175
22
Central Mechanisms of HPA Axis Regulation by Voluntary Exercise
NeuroMolecular Medicine
2008
171
23
The Sympathetic Nervous System and Pain
NeuroMolecular Medicine
2008
170
24
Cannabinoid Receptors and Their Role in Neuroprotection
NeuroMolecular Medicine
2005
169
25
Phospholipases A2 and Inflammatory Responses in the Central Nervous System
NeuroMolecular Medicine
2010
169
26
Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease
NeuroMolecular Medicine
2010
169
27
T-Cells in Alzheimer's Disease
NeuroMolecular Medicine
2005
167
28
Mitochondrial UCP4 Mediates an Adaptive Shift in Energy Metabolism and Increases the Resistance of Neurons to Metabolic and Oxidative Stress
NeuroMolecular Medicine
2006
167
29
Neurotrophic Mechanisms in Drug Addiction
NeuroMolecular Medicine
2004
164
30
Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and Beyond
NeuroMolecular Medicine
2011
162
31
Stroke and T-Cells
NeuroMolecular Medicine
2005
161
32
The Serotonergic System and Anxiety
NeuroMolecular Medicine
2004
153
33
From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure
NeuroMolecular Medicine
2009
150
34
Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease
NeuroMolecular Medicine
2006
149
35
Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease
NeuroMolecular Medicine
2006
148
36
Roles of AMP-activated Protein Kinase in Alzheimer’s Disease
NeuroMolecular Medicine
2012
146
37
Curcumin Nanoparticles Attenuate Neurochemical and Neurobehavioral Deficits in Experimental Model of Huntington’s Disease
NeuroMolecular Medicine
2014
146
38
Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases
NeuroMolecular Medicine
2008
140
39
Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin?
NeuroMolecular Medicine
2010
138
40
The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System
NeuroMolecular Medicine
2010
136
41
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
NeuroMolecular Medicine
2011
135
42
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
NeuroMolecular Medicine
2013
134
43
Exercise, Learned Helplessness, and the Stress-Resistant Brain
NeuroMolecular Medicine
2008
133
44
Metal Ion Physiopathology in Neurodegenerative Disorders
NeuroMolecular Medicine
2009
131
45
Mammalian Neutral Sphingomyelinases: Regulation and Roles in Cell Signaling Responses
NeuroMolecular Medicine
2010
129
46
Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease
NeuroMolecular Medicine
2013
129
47
The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases
NeuroMolecular Medicine
2010
128
48
Protein Accumulation in Traumatic Brain Injury
NeuroMolecular Medicine
2003
126
49
Rett Syndrome and MeCP2
NeuroMolecular Medicine
2014
124
50
Kernicterus and the Molecular Mechanisms of Bilirubin-Induced CNS Injury in Newborns
NeuroMolecular Medicine
2006
122
site/software ©
exaly
; All materials licenced under
CC by-SA
.